Overview
Yangyi He practices practicing medicine in Chengdu, China.
He is highly rated in 1 condition, according to our data. Their clinical expertise encompasses Squamous Cell Lung Carcinoma, Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, and Neurosyphilis.
They are actively involved in clinical research, co-authoring 10 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Yangyi He
Is Yangyi He a top-rated expert for Squamous Cell Lung Carcinoma?
MediFind is an objective health platform that identifies experts based on real-world data. Yangyi He is classified as an Advanced expert for Squamous Cell Lung Carcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Yangyi He participate in research or clinical trials?
Yes. Yangyi He has published 10 articles and abstracts on conditions like Squamous Cell Lung Carcinoma. You can view a list of Yangyi He's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Squamous Cell Lung Carcinoma
- Experienced
- Anti-NMDA Receptor Encephalitis
- Lung CancerHe isExperienced. Learn about Lung Cancer.
- NeurosyphilisHe isExperienced. Learn about Neurosyphilis.
- Non-Small Cell Lung Cancer (NSCLC)